# PK and PD of YG1699 in CKD Patients With Diabetes

> **NCT06648876** · PHASE1 · NOT_YET_RECRUITING · sponsor: **RenJi Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Diabetes
- Renal Insufficiency, Chronic
- Hemodialysis

## Interventions

- **DRUG:** YG1699
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06648876
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-31
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-10-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06648876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06648876, "PK and PD of YG1699 in CKD Patients With Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06648876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*